Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06239350 · ClinicalTrials.gov registry record · NA
Young Adult Tobacco/Nicotine and Cannabis Co-use
A NA study of Tobacco Use Disorder and Nicotine Dependence, sponsored by Medical University of South Carolina.
- Recruiting
- Registry status
- NA
- Development phase
- 350
- Enrollment target
- 1
- Study location
NCT06239350: Recruiting NA study of Tobacco Use Disorder and Nicotine Dependence, sponsored by Medical University of South Carolina.
NCT06239350 is a NA study of Tobacco Use Disorder and Nicotine Dependence that is actively recruiting participants, run by Medical University of South Carolina. The registered enrollment target is 350 participants, above the 234-participant average among 70 other Tobacco Use Disorder trials with a reported enrollment target (50% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06239350, a NA study of Tobacco Use Disorder and Nicotine Dependence, is actively recruiting participants, sponsored by Medical University of South Carolina.
- RECRUITING
- Registry status
- NA
- Development phase
- 350 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this project is to better understand the relationship between tobacco/nicotine and cannabis using behavioral economics during a tobacco/nicotine quit attempt. All participants will receive tobacco/nicotine cessation treatment (smoking and/or vaping treatment) for 12 weeks. To qualify, participants must be between the ages of 18-25 and use tobacco products (smoke cigarettes and/or vape nicotine) and use cannabis (in any form). Participants do not need to be interested in quitting cannabis/marijuana to qualify. This study is being conducted by the Medical University of South Carolina. All procedures are conducted remotely and there is no in-person visits are needed.
Primary Outcome
7-day point prevalence abstinence from all nicotine/tobacco will be assessed at Week 12 through oral fluid cotinine biochemical verification and daily self-reported smoking or vaping.
Conditions Studied
Interventions
- BEHAVIORAL Counseling
- BEHAVIORAL Contingency management
- BEHAVIORAL Text-based support
Study Locations (1)
South Carolina
- Medical University of South Carolina - Charleston - Charleston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 350 participants |
| Start Date | 2024-05-13 |
| Est. Completion | 2028-01-03 |
| Phase | NA |
What NCT06239350 shows while recruiting
NCT06239350 is an interventional study that assigns participants to a tested intervention. The registered 350 participants enrollment target is mid-sized for trials with a published cap, above the 234-participant average among 70 other Tobacco Use Disorder trials with a reported enrollment target (50% higher).
The record links to 2 conditions, with Tobacco Use Disorder appearing as the primary indexed condition, and to 3 interventions - of which Counseling is the first listed.
NCT06239350 reports a single indexed study location in South Carolina.
Frequently Asked Questions
What is clinical trial NCT06239350 about?
NCT06239350 is a clinical study titled "Young Adult Tobacco/Nicotine and Cannabis Co-use". The goal of this project is to better understand the relationship between tobacco/nicotine and cannabis using behavioral economics during a tobacco/nicotine quit attempt. All participants will receive tobacco/nicotine cessation treatment (smoking and/or vaping treatment) for 12 weeks. To qualify, pa...
What is the current status of trial NCT06239350?
This trial is currently recruiting. It is a NA study. The enrollment target is 350 participants. The study started on 2024-05-13. Estimated completion is 2028-01-03.
What conditions does trial NCT06239350 study?
This clinical trial studies the following conditions: Tobacco Use Disorder, Nicotine Dependence.
What interventions are being tested in trial NCT06239350?
The interventions under investigation include: Counseling (BEHAVIORAL), Contingency management (BEHAVIORAL), Text-based support (BEHAVIORAL).
Who is sponsoring clinical trial NCT06239350?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06239350 being conducted?
This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tobacco Use Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06239350's enrollment target sits among peer trials
350 12th of 70 higher than 58 of 70 other Tobacco Use Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Tobacco Use Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Smoking Cessation CM for Veterans With or at Risk for Cancer
RECRUITING · NA
-
Smoking Cessation Behavioral Treatment Study
RECRUITING · NA
-
Contingency Management for Veteran Smokers Undergoing Major Elective Surgery
RECRUITING · NA
-
A Future Thinking Intervention for Comorbid Tobacco Use Disorder and Bipolar Disorder
RECRUITING · NA
-
Low Intensity Focused Ultrasound for Tobacco Use Disorder: High Resolution Targeting of the Human Insula
RECRUITING · NA
-
Quit-Smoking Study for Native Hawaiians
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00900575 · 350 participants · NA
Cervical Cancer Detection Using Optical Spectroscopy
- NCT01627821 · 350 participants · NA
Evaluation of the Jarvik 2000 Left Ventricular Assist System With Post-Auricular Connector--Destination Therapy Study
- NCT02357654 · 350 participants · Phase 4
GnRH for Luteal Support in IVF/ICSI/FET Cycles
- NCT03997370 · 350 participants · Phase 1
Evaluation of Dosing Procedures of Chemotherapy Treatment (Carboplatin) With the Contrast Agent Iohexol
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI